Clinical Trial Update: Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX [NA]

View source ↗

Summary

The study evaluating Enhanced External Counterpulsation (EECP) on VO2 max has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Pulmonary Disease

Snippet

Sponsor: David Grant U.S. Air Force Medical Center | Conditions: Cardiovascular Disease, Pulmonary Disease | NA | Status: WITHDRAWN